International Journal of Clinical Case Reports, 2025, Vol.15, No.4, 171-181 http://medscipublisher.com/index.php/ijccr 180 Major R., Lakhani N., Ahmed Y., Atkin,J., Baines R., Balment R., Cheung C., Graham-Brown M., Ellwood C., Harding L., Iyasere O., Jesa T., Jesus-Silva J., Jinadu Y., Khalid A., Khatri J., Makkeyah Y., Martinez M., Mather H., Medcalf J., Moore K., Ogle J., Oseya E., Patel D., Patel R., Pollard T., Priestman W., Rastogi A., Sanganee N., Shaffu M., Steiner M., Than T., Xu G., Rizvi F., and Burton J., 2025, Integrated primary and secondary care optimizes the management of people with CKD-the LUCID project, Clinical Kidney Journal, 18(4): sfaf049. https://doi.org/10.1093/ckj/sfaf049 Montomoli M., Candía B., Barrios A., and Bernat E., 2024, Anticoagulation in chronic kidney disease, Drugs, 84(10):1199-1218. https://doi.org/10.1007/s40265-024-02077-6 Nakanishi T., Nanami M., and Kuragano T., 2020, The pathogenesis of CKD complications; attack of dysregulated iron and phosphate metabolism, Free Radical Biology and Medicine, 157: 55-62. https://doi.org/10.1016/j.freeradbiomed.2020.01.024 Narasaki Y., Siu M., Nguyen M., Kalantar-Zadeh K., and Rhee C., 2024, Personalized nutritional management in the transition from non-dialysis dependent chronic kidney disease to dialysis, Kidney Research and Clinical Practice, 43(5): 575-585. https://doi.org/10.23876/j.krcp.23.142 Oh T.R., Choi H.S., Kim C.S., Bae E., Ma S.K., Sung, S., Kim Y., Oh, K., Ahn C., and Kim S., 2019, Hyperuricemia has increased the risk of progression of chronic kidney disease: propensity score matching analysis from the KNOW-CKD study, Scientific Reports, 9(1): 6681. https://doi.org/10.1038/s41598-019-43241-3 Padial M., Rebollo A., Jiménez T., Lindholm B., Avesani C., and Olveira G., 2024, #2002 Impact of personalized nutrition care in patients with advanced chronic kidney disease: ERCANUT RCT, Nephrology Dialysis Transplantation, 39(Supplement_1): gfae069-0751. https://doi.org/10.1093/ndt/gfae069.751 Petreski T., Piko N., Ekart R., Hojs R., and Bevc S., 2021, Review on inflammation markers in chronic kidney disease, Biomedicines, 9(2): 182. https://doi.org/10.3390/biomedicines9020182 Pradhan N., Kerner J., Campos L., and Dobre M., 2025, Personalized nutrition in chronic kidney disease, Biomedicines, 13(3): 647. https://doi.org/10.3390/biomedicines13030647 Pugh D., Gallacher P., and Dhaun N., 2019, Management of hypertension in chronic kidney disease, Drugs, 79(4): 365-379. https://doi.org/10.1007/s40265-019-1064-1 Ruíz-Ortega M., Rayego-Mateos S., Lamas S., Ortiz A., and Rodrigues-Díez R., 2020, Targeting the progression of chronic kidney disease, Nature Reviews Nephrology, 16(5): 269-288. https://doi.org/10.1038/s41581-019-0248-y Sabanayagam C., Banu R., Lim C., Tham Y., Cheng C., Tan G., Ekinci E., Sheng B., McKay G., Shaw J., Matsushita K., Tangri N., Choo J., and Wong T., 2025, Artificial intelligence in chronic kidney disease management: a scoping review, Theranostics, 15: 4566-4578. https://doi.org/10.7150/thno.108552 Shabaka A., Cases-Corona C., and Fernández-Juárez G., 2021, Therapeutic insights in chronic kidney disease progression, Frontiers in Medicine, 8: 645187. https://doi.org/10.3389/fmed.2021.645187 Shen H., Van Der Kleij R., Van Der Boog P., Chang X., and Chavannes N., 2019, Electronic health self-management interventions for patients with chronic kidney disease: systematic review of quantitative and qualitative evidence, Journal of Medical Internet Research, 21(11): e12384. https://doi.org/10.2196/12384 Shi Y., Xiong J., Chen Y., Deng J., Peng H., Zhao J., and He J., 2017, The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis, International Urology and Nephrology, 50: 301-312. https://doi.org/10.1007/s11255-017-1679-7 Sinha A., and Agarwal R., 2018, Clinical pharmacology of antihypertensive therapy for the treatment of hypertension in CKD, Clinical Journal of the American Society of Nephrology, 14(5): 757-764. https://doi.org/10.2215/CJN.04330418 Speer T., Dimmeler S., Schunk S., Fliser D., and Ridker P., 2022, Targeting innate immunity-driven inflammation in CKD and cardiovascular disease, Nature Reviews Nephrology, 18(12): 762-778. https://doi.org/10.1038/s41581-022-00621-9 Tarun T., Ghanta S., Ong V., Kore, R., Menon L., Kovesdy C., Mehta J., and Jain N., 2023, Updates on new therapies for patients with CKD, Kidney International Reports, 9(1): 16-28. https://doi.org/10.1016/j.ekir.2023.10.006 Tinti F., Lai S., Noce A., Rotondi S., Marrone G., Mazzaferro S., Di Daniele N., and Mitterhofer A., 2021, Chronic kidney disease as a systemic inflammatory syndrome: update on mechanisms involved and potential treatment, Life, 11(5): 419. https://doi.org/10.3390/life11050419 Vaziri N., Zhao Y., and Pahl M., 2016, Altered intestinal microbial flora and impaired epithelial barrier structure and function in CKD: the nature, mechanisms, consequences and potential treatment, Nephrology, Dialysis, Transplantation, 31(5): 737-746. https://doi.org/10.1093/ndt/gfv095 Wang Q., Ge M., Sun H., Xu Q., Li H., and Lv G., 2022, Systematic review and meta-analysis program based on effectiveness of a multidisciplinary model of care for patients with chronic kidney disease, Contrast Media and Molecular Imaging, 2022(1): 4315361. https://doi.org/10.1155/2022/4315361
RkJQdWJsaXNoZXIy MjQ4ODYzNA==